J&J, Legend cell therapy approved by FDA for multiple myeloma

The Food and Drug Administration on Monday approved a powerful new blood cancer treatment, clearing a personalized cell therapy developed by Johnson & Johnson and China's Legend Biotech for use in multiple myeloma.